questionsmedicales.fr
Maladies cardiovasculaires
Maladies vasculaires
Vascularite
Vascularite : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Vascularite
Biopsie
Imagerie médicale
Tests sanguins
Inflammation
Vitesse de sédimentation
Symptômes
Fatigue
Éruption cutanée
Biopsie
Diagnostic
Vascularite
Rhumatologie
Médecine interne
Vascularite
Symptômes
5
Symptômes
Fatigue
Éruption cutanée
Douleurs articulaires
Vascularite
Symptômes
Symptômes neurologiques
Vascularite
Engourdissement
Éruption cutanée
Purpura
Vascularite
Organes internes
Complications
Vascularite
Prévention
5
Prévention
Suivi médical
Vascularite
Vaccination
Prévention
Infections
Déclencheurs
Prévention
Vascularite
Suivi médical
Vascularite
Traitement
Alimentation
Antioxydants
Vascularite
Traitements
5
Corticostéroïdes
Immunosuppresseurs
Traitement
Corticostéroïdes
Inflammation
Vascularite
Immunosuppresseurs
Vascularite
Traitement
Thérapies biologiques
Vascularite
Traitement
Traitement
Vascularite
Suivi médical
Complications
5
Complications
Lésions organiques
Vascularite
Insuffisance rénale
Complications
Vascularite
Risques cardiovasculaires
AVC
Vascularite
Complications
Traitement
Vascularite
Surveillance
Examens médicaux
Vascularite
Facteurs de risque
5
Facteurs de risque
Antécédents familiaux
Vascularite
Âge
Facteurs de risque
Vascularite
Infections
Déclencheurs
Vascularite
Tabagisme
Facteurs de risque
Vascularite
Maladies auto-immunes
Facteurs de risque
Vascularite
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Vascularite : Questions médicales les plus fréquentes",
"headline": "Vascularite : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Vascularite : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-06-06",
"dateModified": "2025-03-03",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Vascularite"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Maladies vasculaires",
"url": "https://questionsmedicales.fr/mesh/D014652",
"about": {
"@type": "MedicalCondition",
"name": "Maladies vasculaires",
"code": {
"@type": "MedicalCode",
"code": "D014652",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C14.907"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Aortite",
"alternateName": "Aortitis",
"url": "https://questionsmedicales.fr/mesh/D001025",
"about": {
"@type": "MedicalCondition",
"name": "Aortite",
"code": {
"@type": "MedicalCode",
"code": "D001025",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C14.907.940.080"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Artérite",
"alternateName": "Arteritis",
"url": "https://questionsmedicales.fr/mesh/D001167",
"about": {
"@type": "MedicalCondition",
"name": "Artérite",
"code": {
"@type": "MedicalCode",
"code": "D001167",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C14.907.940.090"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Endartérite",
"alternateName": "Endarteritis",
"url": "https://questionsmedicales.fr/mesh/D004692",
"about": {
"@type": "MedicalCondition",
"name": "Endartérite",
"code": {
"@type": "MedicalCode",
"code": "D004692",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C14.907.940.090.340"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Syndrome de Cogan",
"alternateName": "Cogan Syndrome",
"url": "https://questionsmedicales.fr/mesh/D055952",
"about": {
"@type": "MedicalCondition",
"name": "Syndrome de Cogan",
"code": {
"@type": "MedicalCode",
"code": "D055952",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C14.907.940.320"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Phlébite",
"alternateName": "Phlebitis",
"url": "https://questionsmedicales.fr/mesh/D010689",
"about": {
"@type": "MedicalCondition",
"name": "Phlébite",
"code": {
"@type": "MedicalCode",
"code": "D010689",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C14.907.940.740"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Thrombophlébite",
"alternateName": "Thrombophlebitis",
"url": "https://questionsmedicales.fr/mesh/D013924",
"about": {
"@type": "MedicalCondition",
"name": "Thrombophlébite",
"code": {
"@type": "MedicalCode",
"code": "D013924",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C14.907.940.740.910"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Syndrome de Lemierre",
"alternateName": "Lemierre Syndrome",
"url": "https://questionsmedicales.fr/mesh/D057831",
"about": {
"@type": "MedicalCondition",
"name": "Syndrome de Lemierre",
"code": {
"@type": "MedicalCode",
"code": "D057831",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C14.907.940.740.910.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Syndrome de Lemierre",
"alternateName": "Lemierre Syndrome",
"url": "https://questionsmedicales.fr/mesh/D057831",
"about": {
"@type": "MedicalCondition",
"name": "Syndrome de Lemierre",
"code": {
"@type": "MedicalCode",
"code": "D057831",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C14.907.940.740.910.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Vascularite rétinienne",
"alternateName": "Retinal Vasculitis",
"url": "https://questionsmedicales.fr/mesh/D031300",
"about": {
"@type": "MedicalCondition",
"name": "Vascularite rétinienne",
"code": {
"@type": "MedicalCode",
"code": "D031300",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C14.907.940.815"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vascularite systémique",
"alternateName": "Systemic Vasculitis",
"url": "https://questionsmedicales.fr/mesh/D056647",
"about": {
"@type": "MedicalCondition",
"name": "Vascularite systémique",
"code": {
"@type": "MedicalCode",
"code": "D056647",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C14.907.940.897"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Thromboangéite oblitérante",
"alternateName": "Thromboangiitis Obliterans",
"url": "https://questionsmedicales.fr/mesh/D013919",
"about": {
"@type": "MedicalCondition",
"name": "Thromboangéite oblitérante",
"code": {
"@type": "MedicalCode",
"code": "D013919",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C14.907.940.905"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Vascularite",
"alternateName": "Vasculitis",
"code": {
"@type": "MedicalCode",
"code": "D014657",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "David S Younger",
"url": "https://questionsmedicales.fr/author/David%20S%20Younger",
"affiliation": {
"@type": "Organization",
"name": "Department of Medicine, Section of Neuroscience, City University of New York School of Medicine, New York, NY, USA; Department of Neurology, White Plains Hospital, White Plains, NY, USA. Electronic address: youngd01@nyu.edu."
}
},
{
"@type": "Person",
"name": "Tanaz A Kermani",
"url": "https://questionsmedicales.fr/author/Tanaz%20A%20Kermani",
"affiliation": {
"@type": "Organization",
"name": "Division of Rheumatology, University of California, Los Angeles, Los Angeles, CA, USA."
}
},
{
"@type": "Person",
"name": "Christian Pagnoux",
"url": "https://questionsmedicales.fr/author/Christian%20Pagnoux",
"affiliation": {
"@type": "Organization",
"name": "Department of Medicine, Division of Rheumatology, Mount Sinai Hospital, Toronto."
}
},
{
"@type": "Person",
"name": "Cristina Ponte",
"url": "https://questionsmedicales.fr/author/Cristina%20Ponte",
"affiliation": {
"@type": "Organization",
"name": "Rheumatology Department, Hospital de Santa Maria - Centro Hospitalar Universitário Lisboa Norte, Centro Académico de Medicina de Lisboa, Lisbon, Portugal. cristinadbponte@gmail.com."
}
},
{
"@type": "Person",
"name": "Nikita Khmelinskii",
"url": "https://questionsmedicales.fr/author/Nikita%20Khmelinskii",
"affiliation": {
"@type": "Organization",
"name": "Rheumatology Department, Hospital de Santa Maria - Centro Hospitalar Universitário Lisboa Norte, Centro Académico de Medicina de Lisboa, Lisbon, Portugal."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Endothelial-derived complement factor D contributes to endothelial dysfunction in malignant nephrosclerosis via local complement activation.",
"datePublished": "2023-05-15",
"url": "https://questionsmedicales.fr/article/37188751",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41440-023-01300-3"
}
},
{
"@type": "ScholarlyArticle",
"name": "Quantification of the zymogenicity and the substrate-induced activity enhancement of complement factor D.",
"datePublished": "2023-05-22",
"url": "https://questionsmedicales.fr/article/37283768",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fimmu.2023.1197023"
}
},
{
"@type": "ScholarlyArticle",
"name": "Quantification of the pro-form of human complement component factor D (adipsin).",
"datePublished": "2022-06-06",
"url": "https://questionsmedicales.fr/article/35679953",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jim.2022.113295"
}
},
{
"@type": "ScholarlyArticle",
"name": "Complement factors D and C3 cross-sectionally associate with arterial stiffness, but not independently of metabolic risk factors: The Maastricht Study.",
"datePublished": "2022-07-25",
"url": "https://questionsmedicales.fr/article/35881455",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/HJH.0000000000003237"
}
},
{
"@type": "ScholarlyArticle",
"name": "Urinary complement factor D is increased in primary malignant hypertension: a single-center, cross-sectional study.",
"datePublished": "2024-07-15",
"url": "https://questionsmedicales.fr/article/39009768",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41598-024-66875-4"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Maladies cardiovasculaires",
"item": "https://questionsmedicales.fr/mesh/D002318"
},
{
"@type": "ListItem",
"position": 3,
"name": "Maladies vasculaires",
"item": "https://questionsmedicales.fr/mesh/D014652"
},
{
"@type": "ListItem",
"position": 4,
"name": "Vascularite",
"item": "https://questionsmedicales.fr/mesh/D014657"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Vascularite - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Vascularite",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-14",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Vascularite",
"description": "Comment diagnostiquer une vascularite ?\nQuels tests sanguins sont utilisés ?\nQuels symptômes indiquent une vascularite ?\nLa biopsie est-elle toujours nécessaire ?\nQuels spécialistes consultent pour une vascularite ?",
"url": "https://questionsmedicales.fr/mesh/D014657?mesh_terms=Complement+Factor+D#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Vascularite",
"description": "Quels sont les symptômes courants de la vascularite ?\nLa vascularite peut-elle causer des douleurs articulaires ?\nY a-t-il des symptômes neurologiques associés ?\nLes éruptions cutanées sont-elles spécifiques ?\nLa vascularite peut-elle affecter les organes internes ?",
"url": "https://questionsmedicales.fr/mesh/D014657?mesh_terms=Complement+Factor+D#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Vascularite",
"description": "Peut-on prévenir la vascularite ?\nLes vaccinations sont-elles recommandées ?\nComment éviter les déclencheurs ?\nLe suivi médical est-il important ?\nY a-t-il des conseils diététiques ?",
"url": "https://questionsmedicales.fr/mesh/D014657?mesh_terms=Complement+Factor+D#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Vascularite",
"description": "Quels traitements sont disponibles pour la vascularite ?\nLes corticostéroïdes sont-ils efficaces ?\nQuand utilise-t-on des immunosuppresseurs ?\nY a-t-il des traitements alternatifs ?\nLe traitement est-il à long terme ?",
"url": "https://questionsmedicales.fr/mesh/D014657?mesh_terms=Complement+Factor+D#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Vascularite",
"description": "Quelles sont les complications possibles de la vascularite ?\nLa vascularite peut-elle entraîner des problèmes rénaux ?\nQuels risques cardiovasculaires sont associés ?\nLes complications sont-elles réversibles ?\nComment surveiller les complications ?",
"url": "https://questionsmedicales.fr/mesh/D014657?mesh_terms=Complement+Factor+D#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Vascularite",
"description": "Quels sont les facteurs de risque de la vascularite ?\nL'âge influence-t-il le risque de vascularite ?\nLes infections peuvent-elles déclencher une vascularite ?\nLe tabagisme est-il un facteur de risque ?\nCertaines maladies auto-immunes augmentent-elles le risque ?",
"url": "https://questionsmedicales.fr/mesh/D014657?mesh_terms=Complement+Factor+D#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une vascularite ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur des analyses sanguines, des biopsies et des examens d'imagerie."
}
},
{
"@type": "Question",
"name": "Quels tests sanguins sont utilisés ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests comme la vitesse de sédimentation et les marqueurs inflammatoires sont courants."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une vascularite ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Symptômes incluent fatigue, fièvre, douleurs articulaires et éruptions cutanées."
}
},
{
"@type": "Question",
"name": "La biopsie est-elle toujours nécessaire ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, elle est souvent utilisée si les tests sanguins ne sont pas concluants."
}
},
{
"@type": "Question",
"name": "Quels spécialistes consultent pour une vascularite ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les rhumatologues et les médecins internistes sont souvent impliqués dans le diagnostic."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants de la vascularite ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent fatigue, fièvre, douleurs musculaires et éruptions cutanées."
}
},
{
"@type": "Question",
"name": "La vascularite peut-elle causer des douleurs articulaires ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les douleurs articulaires sont fréquentes et peuvent être sévères."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes neurologiques associés ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des maux de tête, des troubles de la vision et des engourdissements peuvent survenir."
}
},
{
"@type": "Question",
"name": "Les éruptions cutanées sont-elles spécifiques ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles peuvent varier, mais souvent apparaissent sous forme de plaques ou de purpura."
}
},
{
"@type": "Question",
"name": "La vascularite peut-elle affecter les organes internes ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut toucher les reins, les poumons et le cœur, entraînant des complications."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir la vascularite ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas de méthode de prévention spécifique, mais un suivi médical régulier aide."
}
},
{
"@type": "Question",
"name": "Les vaccinations sont-elles recommandées ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les vaccinations peuvent aider à prévenir certaines infections qui aggravent la vascularite."
}
},
{
"@type": "Question",
"name": "Comment éviter les déclencheurs ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter le tabac, le stress et les infections peut réduire les risques de poussées."
}
},
{
"@type": "Question",
"name": "Le suivi médical est-il important ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un suivi régulier permet d'ajuster le traitement et de surveiller les symptômes."
}
},
{
"@type": "Question",
"name": "Y a-t-il des conseils diététiques ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée et riche en antioxydants peut soutenir la santé vasculaire."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour la vascularite ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les corticostéroïdes et les immunosuppresseurs sont couramment utilisés."
}
},
{
"@type": "Question",
"name": "Les corticostéroïdes sont-ils efficaces ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils réduisent l'inflammation et soulagent les symptômes rapidement."
}
},
{
"@type": "Question",
"name": "Quand utilise-t-on des immunosuppresseurs ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils sont utilisés pour les cas graves ou réfractaires aux corticostéroïdes."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements alternatifs ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des thérapies biologiques peuvent être envisagées dans certains cas spécifiques."
}
},
{
"@type": "Question",
"name": "Le traitement est-il à long terme ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Cela dépend de la gravité et de la réponse au traitement, souvent plusieurs mois."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles de la vascularite ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des lésions organiques, des AVC et des problèmes cardiaques."
}
},
{
"@type": "Question",
"name": "La vascularite peut-elle entraîner des problèmes rénaux ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut causer une insuffisance rénale aiguë ou chronique."
}
},
{
"@type": "Question",
"name": "Quels risques cardiovasculaires sont associés ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les patients peuvent avoir un risque accru de maladies cardiaques et d'AVC."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles réversibles ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être réversibles avec un traitement précoce."
}
},
{
"@type": "Question",
"name": "Comment surveiller les complications ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des examens réguliers et des tests de fonction organique sont essentiels."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque de la vascularite ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent des antécédents familiaux, des infections et certains médicaments."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le risque de vascularite ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines formes de vascularite sont plus fréquentes chez les personnes âgées."
}
},
{
"@type": "Question",
"name": "Les infections peuvent-elles déclencher une vascularite ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des infections virales ou bactériennes peuvent être des déclencheurs."
}
},
{
"@type": "Question",
"name": "Le tabagisme est-il un facteur de risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme est associé à un risque accru de vascularite."
}
},
{
"@type": "Question",
"name": "Certaines maladies auto-immunes augmentent-elles le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des maladies comme le lupus ou la polyarthrite rhumatoïde sont des facteurs de risque."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 03/03/2025
Contenu vérifié selon les dernières recommandations médicales
3 publications dans cette catégorie
Affiliations :
Department of Medicine, Section of Neuroscience, City University of New York School of Medicine, New York, NY, USA; Department of Neurology, White Plains Hospital, White Plains, NY, USA. Electronic address: youngd01@nyu.edu.
Publications dans "Vascularite" :
3 publications dans cette catégorie
Affiliations :
Division of Rheumatology, University of California, Los Angeles, Los Angeles, CA, USA.
Publications dans "Vascularite" :
3 publications dans cette catégorie
Affiliations :
Department of Medicine, Division of Rheumatology, Mount Sinai Hospital, Toronto.
Publications dans "Vascularite" :
2 publications dans cette catégorie
Affiliations :
Rheumatology Department, Hospital de Santa Maria - Centro Hospitalar Universitário Lisboa Norte, Centro Académico de Medicina de Lisboa, Lisbon, Portugal. cristinadbponte@gmail.com.
Unidade de Investigação em Reumatologia, Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal. cristinadbponte@gmail.com.
Publications dans "Vascularite" :
2 publications dans cette catégorie
Affiliations :
Rheumatology Department, Hospital de Santa Maria - Centro Hospitalar Universitário Lisboa Norte, Centro Académico de Medicina de Lisboa, Lisbon, Portugal.
Unidade de Investigação em Reumatologia, Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal.
Publications dans "Vascularite" :
2 publications dans cette catégorie
Affiliations :
Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK.
National Institute for Health Research Leeds Biomedical Research Centre, Leeds Teaching Hospitals, Leeds, UK.
Publications dans "Vascularite" :
2 publications dans cette catégorie
Affiliations :
University of Groningen, University Medical Center Groningen, Groningen, the Netherlands. Electronic address: e.brouwer@umcg.nl.
Publications dans "Vascularite" :
2 publications dans cette catégorie
Affiliations :
Division of Rheumatology, Department of Pediatrics, Faculty of Medicine, Hacettepe University, Hacettepe University Vasculitis Research Center, Ankara, Turkey.
Publications dans "Vascularite" :
2 publications dans cette catégorie
Affiliations :
Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
Publications dans "Vascularite" :
2 publications dans cette catégorie
Affiliations :
Department of Medicine, Division of Pulmonary and Critical Care Medicine.
Publications dans "Vascularite" :
2 publications dans cette catégorie
Affiliations :
Department of Medicine, Division of Rheumatology, Mayo Clinic, Rochester, MN, USA.
Publications dans "Vascularite" :
2 publications dans cette catégorie
Affiliations :
Department of Medicine, Division of Rheumatology and Division of Clinical Epidemiology, University of Pennsylvania, Philadelphia, PA.
Publications dans "Vascularite" :
2 publications dans cette catégorie
Publications dans "Vascularite" :
2 publications dans cette catégorie
Affiliations :
Musgrove Park Hospital, Taunton, UK.
Publications dans "Vascularite" :
2 publications dans cette catégorie
Affiliations :
North Bristol Trust, Bristol, UK matthew.wells@nbt.nhs.uk.
Publications dans "Vascularite" :
2 publications dans cette catégorie
Affiliations :
North Bristol Trust, Bristol, UK.
Publications dans "Vascularite" :
2 publications dans cette catégorie
Affiliations :
North Bristol Trust, Bristol, UK.
Publications dans "Vascularite" :
2 publications dans cette catégorie
Affiliations :
North Bristol Trust, Bristol, UK.
Publications dans "Vascularite" :
2 publications dans cette catégorie
Affiliations :
Mayo Clinic, Phoenix, Arizona, USA.
Publications dans "Vascularite" :
2 publications dans cette catégorie
Affiliations :
Department of Paediatrics, University of Zagreb School of Medicine, University Hospital Centre Zagreb, Zagreb, Croatia.
Publications dans "Vascularite" :
Malignant nephrosclerosis is a thrombotic microangiopathy associated with abnormal local activation of the complement alternative pathway (AP). However, the mechanism underlying local AP activation is...
Complement factor D (FD) is a serine protease present predominantly in the active form in circulation. It is synthesized as a zymogen (pro-FD), but it is continuously converted to FD by circulating ac...
Factor D (also known as adipsin) is a serine protease and part of the complement system, involved in innate immune responses and effector functions of antibodies. Factor D cleaves factor B complexed w...
Arterial stiffness predicts cardiovascular outcomes. The complement system, particularly the alternative complement pathway, has been implicated in cardiovascular diseases. We herein investigated the ...
In 3019 population-based participants (51.9% men, 60.1 ± 8.2 years, 27.7% type 2 diabetes [T2D], oversampled]), we measured carotid-femoral pulse wave velocity (cfPWV), carotid distensibility coeffici...
Per SD higher factors D and C3, cfPWV was 0.41 m/s [95% confidence interval: 0.34; 0.49] and 0.33 m/s [0.25; 0.41] greater, respectively. These associations were substantially attenuated when adjusted...
The strong association of plasma factors D and C3 with arterial stiffness in this population-based cohort was not independent of T2D and other metabolic risk factors. Our data suggest that a possible ...
Kidney injury is one of the detrimental consequences of primary malignant hypertension (pMHTN). There is a paucity of non-invasive biomarkers to enhance diagnosis and elucidate the underlying mechanis...
Dense connective tissues (DCTs) such as tendon, ligament, and cartilage are important stabilizers and force transmitters in the musculoskeletal system. The healing processes after DCT injuries are hig...
Quantitative mass spectrometry (QMS) profiling of tissue biopsies from the inflammatory phase of healing (n = 40 patients) and microdialysates from the proliferative phase of healing (n = 28 patients)...
The QMS profiling of tissue biopsies from the inflammatory phase of healing identified 769 unique proteins, and microdialysates from the proliferative phase of healing identified 1423 unique proteins ...
The results of the current studies characterized underlying inflammatory- and proliferative healing mechanisms by which CFD potentially improved tendon repair. These findings may lead to improved indi...
http://clinicaltrials.gov, identifiers NCT02318472, NCT01317160....
C3 glomerulopathy (C3G) is a rare, progressive kidney disease resulting from dysregulation of the alternative pathway (AP) of complement. Biomarkers at baseline were investigated in patients with C3G ...
Patients with biopsy-confirmed C3G, proteinuria ≥500 mg/day, and estimated glomerular filtration rate (eGFR) ≥30 mL/min/1.73 m2 were enrolled into two studies (NCT03369236 and NCT03459443). Biomarker ...
Twenty-nine patients were included in the analysis (median [interquartile range] age: 24.0 [10.0] years). Systemic complement AP activation was evident by reduced median concentrations of C3 and C5, e...
Associations among complement biomarkers, kidney function, and kidney histology may add to the current understanding of C3G and assist with the characterization of patients with this heterogenous dise...
Complement-mediated diseases or complementopathies, such as Paroxysmal nocturnal hemoglobinuria (PNH), cold agglutinin disease (CAD), and transplant-associated thrombotic microangiopathy (TA-TMA), dem...
A54145 factor D (A5D) is a cyclic lipopeptide antibiotic that shares several structural and mechanistic features with the clinically important antibiotic daptomycin, such as their requirement for calc...
Complement pathway proteins are reported to be increased in polycystic ovary syndrome (PCOS) and may be affected by obesity and insulin resistance. To investigate this, a proteomic analysis of the com...